IP Library Granted Patent US 12,311,167
Granted Patent B2
US 12,311,167 · App. 17/751,215 · Granted May 27, 2025

Delivering alternating electric fields (e.g., TTFields) to a subject's spinal anatomy

Inventors: Zeev Bomzon (Kiryat Tivon, IL); Ariel Naveh (Haifa, IL); Ofir Yesharim (Haifa, IL)
Assignee: Novocure GmbH
A61N1/36002A61N1/0408A61N1/36034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,311,167
App. No.
17/751,215
Granted
May 27, 2025
Kind
B2
Abstract

Alternating electric fields (e.g., TTFields) can be delivered at a therapeutically effective strength to a target region of the spinal anatomy. In some embodiments, first and second sets of electrode elements are positioned with their centroids adjacent to upper and lower portions of the person's spine, respectively. In other embodiments, a first set of electrode elements is positioned with its centroid on an upper surface of the person's head, and a second set of electrode elements is positioned with its centroid adjacent to the person's spine (e.g., below the L3 vertebrae). Applying an AC voltage between the first and second sets of electrode elements generates a generally vertical field in the target region at levels that are not achievable using other layouts for positioning the electrode elements on the subject's body. These configurations are particularly useful for preventing and/or treating metastases.

Claims (22)

1. A method of determining where to position a first set of electrode elements having a first centroid and a second set of electrode elements having a second centroid on a person's body before the first and second sets of electrode elements are used to apply an alternating electric field to a target region in the person's spinal anatomy, the method comprising:

identifying a location of a tumor in the person's spinal anatomy;

outputting, based on the identified location, a recommendation for positioning the first and second sets of electrode elements, wherein the recommendation is either (a) to affix the first set of electrode elements to the person's back with the first centroid positioned adjacent to an upper portion of the person's spine, and to affix the second set of electrode elements with the second centroid positioned adjacent to a lower portion of the person's spine or (b) to affix the first set of electrode elements to the person's head with the first centroid positioned on an upper surface of the person's head, and to affix the second set of electrode elements to the person's back with the second centroid positioned adjacent to the person's spine,

wherein the recommendation for positioning the first and second sets of electrode elements is made by

(a) simulating affixation of a first set of electrode elements to the person's back at each of a first plurality of positions with the first centroid positioned adjacent to an upper portion of the person's spine,

(b) simulating affixation of a second set of electrode elements to the person's back at each of a second plurality of positions with the second centroid positioned adjacent to a lower portion of the person's spine,

(c) simulating the alternating electric field that will be produced when an alternating voltage is applied between the first set of electrode elements and the second set of electrode elements at each of the first plurality of positions and at each of the second plurality of positions, respectively, and

(d) determining, based on step (c), which of the first plurality of positions and which of the second plurality of positions results in an optimized alternating electric field in the target region;

positioning the first and second sets of electrode elements on the person's body based on the recommendation; and

applying an alternating voltage between the first set of electrode elements and the second set of electrode elements to impose an electric field in the target region.

2. The method of claim 1 , wherein step (d) comprises determining which of the first plurality of positions and which of the second plurality of positions (i) maximizes a portion of the target region that has a field strength of at least 1 V/cm, (ii) maximizes uniformity of the field in the target region, or (iii) maximizes the intensity of the field in the target region.

3. A method of determining where to position a first set of electrode elements having a first centroid and a second set of electrode elements having a second centroid on a person's body before the first and second sets of electrode elements are used to apply an alternating electric field to a target region in the person's spinal anatomy, the method comprising:

identifying a location of a tumor in the person's spinal anatomy;

outputting, based on the identified location, a recommendation for positioning the first and second sets of electrode elements, wherein the recommendation is either (a) to affix the first set of electrode elements to the person's back with the first centroid positioned adjacent to an upper portion of the person's spine, and to affix the second set of electrode elements with the second centroid positioned adjacent to a lower portion of the person's spine or (b) to affix the first set of electrode elements to the person's head with the first centroid positioned on an upper surface of the person's head, and to affix the second set of electrode elements to the person's back with the second centroid positioned adjacent to the person's spine,

wherein the recommendation for positioning the first and second sets of electrode elements is made by

(a) simulating affixation of a first set of electrode elements to the person's head at each of a first plurality of positions with the first centroid positioned on an upper surface of the person's head,

(b) simulating affixation of a second set of electrode elements to the person's back at each of a second plurality of positions with the second centroid positioned adjacent to the person's spine,

(c) simulating the alternating electric field that will be produced when an alternating voltage is applied between the first set of electrode elements and the second set of electrode elements at each of the first plurality of positions and at each of the second plurality of positions, respectively, and

(d) determining, based on step (c), which of the first plurality of positions and which of the second plurality of positions results in an optimized alternating electric field in the target region;

positioning the first and second sets of electrode elements on the person's body based on the recommendation; and

applying an alternating voltage between the first set of electrode elements and the second set of electrode elements to impose an electric field in the target region.

4. The method of claim 3 , wherein step (d) comprises determining which of the first plurality of positions and which of the second plurality of positions (i) maximizes a portion of the target region that has a field strength of at least 1 V/cm, (ii) maximizes uniformity of the field in the target region, or (iii) maximizes the intensity of the field in the target region.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2022
From: BOMZON, ZEEV; NAVEH, ARIEL; YESHARIM, OFIR
To: NOVOCURE GMBH
Reel/Frame 060192/0801 →
Continuity (4)
Division 16664308 · Oct 25, 2019
Provisional Application 62781358 · Dec 18, 2018
Provisional Application 62750315 · Oct 25, 2018
Related Publication 20220280787A1 · Sep 8, 2022
References Cited (114)
US 6169924B1 · Meloy · 2001 [cited by examiner]
US 6868289B2 · Palti · 2005 [cited by applicant]
US 7016725B2 · Palti · 2006 [cited by applicant]
US 7089054B2 · Palti · 2006 [cited by applicant]
US 7136699B2 · Palti · 2006 [cited by applicant]
US 7146210B2 · Palti · 2006 [cited by applicant]
US 7333852B2 · Palti · 2008 [cited by applicant]
US 7467011B2 · Palti · 2008 [cited by applicant]
US 7519420B2 · Palti · 2009 [cited by applicant]
US 7565205B2 · Palti · 2009 [cited by applicant]
US 7565206B2 · Palti · 2009 [cited by applicant]
US 7599745B2 · Palti · 2009 [cited by applicant]
US 7599746B2 · Palti · 2009 [cited by applicant]
US 7706890B2 · Palti · 2010 [cited by applicant]
US 7715921B2 · Palti · 2010 [cited by applicant]
US 7805201B2 · Palti · 2010 [cited by applicant]
US 7890183B2 · Palti · 2011 [cited by examiner]
US 7912540B2 · Palti · 2011 [cited by applicant]
US 7917227B2 · Palti · 2011 [cited by applicant]
US 8019414B2 · Palti · 2011 [cited by applicant]
US 8027738B2 · Palti · 2011 [cited by applicant]
US 8170684B2 · Palti · 2012 [cited by applicant]
US 8175698B2 · Palti et al. · 2012 [cited by applicant]
US 8229555B2 · Palti · 2012 [cited by applicant]
US RE43618E · Palti · 2012 [cited by applicant]
US 8244345B2 · Palti · 2012 [cited by applicant]
US 8406870B2 · Palti · 2013 [cited by applicant]
US 8447395B2 · Palti et al. · 2013 [cited by applicant]
US 8447396B2 · Palti et al. · 2013 [cited by applicant]
US 8465533B2 · Palti · 2013 [cited by applicant]
US 8706261B2 · Palti · 2014 [cited by applicant]
US 8715203B2 · Paiti · 2014 [cited by applicant]
US 8718756B2 · Palti · 2014 [cited by applicant]
US 8764675B2 · Palti · 2014 [cited by applicant]
US 9023090B2 · Palti · 2015 [cited by applicant]
US 9023091B2 · Palti · 2015 [cited by applicant]
US 9039674B2 · Palti et al. · 2015 [cited by applicant]
US 9056203B2 · Palti et al. · 2015 [cited by applicant]
US 9440068B2 · Palti et al. · 2016 [cited by applicant]
US 9655669B2 · Palti et al. · 2017 [cited by applicant]
US 9750934B2 · Palti et al. · 2017 [cited by applicant]
US 9910453B2 · Wasserman et al. · 2018 [cited by applicant]
US 10188851B2 · Wenger et al. · 2019 [cited by applicant]
US 10441776B2 · Kirson et al. · 2019 [cited by applicant]
US 10779875B2 · Palti et al. · 2020 [cited by applicant]
US 10953209B2 · Story et al. · 2021 [cited by applicant]
US 10967167B2 · Hagemann et al. · 2021 [cited by applicant]
US 11097101B2 · Wasserman et al. · 2021 [cited by applicant]
US 11103698B2 · Chang et al. · 2021 [cited by applicant]
US 11109773B2 · Urman et al. · 2021 [cited by applicant]
US 11154707B2 · Bomzon et al. · 2021 [cited by applicant]
US 11191956B2 · Giladi et al. · 2021 [cited by applicant]
US 11224741B2 · Kirson et al. · 2022 [cited by applicant]
US 11241577B2 · Bomzon et al. · 2022 [cited by applicant]
US 11276171B2 · Shamir et al. · 2022 [cited by applicant]
US 11291837B2 · Wasserman et al. · 2022 [cited by applicant]
US 11298422B2 · Krex et al. · 2022 [cited by applicant]
US 20050125045A1 · Brighton et al. · 2005 [cited by applicant]
US 20060167499A1 · Palti · 2006 [cited by applicant]
US 20070225766A1 · Palti · 2007 [cited by applicant]
US 20070239213A1 · Palti · 2007 [cited by applicant]
US 20080208287A1 · Palermo · 2008 [cited by examiner]
US 20110137229A1 · Palti · 2011 [cited by examiner]
US 20120149968A1 · Brighton · 2012 [cited by examiner]
US 20120283726A1 · Palti · 2012 [cited by applicant]
US 20160022986A1 · Travers et al. · 2016 [cited by applicant]
US 20170120041A1 · Wenger et al. · 2017 [cited by applicant]
US 20170215939A1 · Palti et al. · 2017 [cited by applicant]
US 20170281934A1 · Giladi et al. · 2017 [cited by applicant]
US 20180001075A1 · Kirson · 2018 [cited by examiner]
US 20180008708A1 · Giladi et al. · 2018 [cited by applicant]
US 20180050200A1 · Wasserman et al. · 2018 [cited by applicant]
US 20180160933A1 · Urman et al. · 2018 [cited by applicant]
US 20180202991A1 · Giladi et al. · 2018 [cited by applicant]
US 20180333574A1 · Pal · 2018 [cited by examiner]
US 20190117956A1 · Wenger et al. · 2019 [cited by applicant]
US 20190307781A1 · Krex et al. · 2019 [cited by applicant]
US 20190308016A1 · Wenger et al. · 2019 [cited by applicant]
US 20200001069A1 · Kirson et al. · 2020 [cited by applicant]
US 20200009376A1 · Chang et al. · 2020 [cited by applicant]
US 20200009377A1 · Chang et al. · 2020 [cited by applicant]
US 20200016067A1 · Gotlib et al. · 2020 [cited by applicant]
US 20200023179A1 · Bomzon et al. · 2020 [cited by applicant]
US 20200061360A1 · Hagemann et al. · 2020 [cited by applicant]
US 20200061361A1 · Hagemann et al. · 2020 [cited by applicant]
US 20200069937A1 · Naveh et al. · 2020 [cited by applicant]
US 20200078582A1 · Alon et al. · 2020 [cited by applicant]
US 20200108031A1 · Borst et al. · 2020 [cited by applicant]
US 20200121728A1 · Wardak et al. · 2020 [cited by applicant]
US 20200129761A1 · Bomzon et al. · 2020 [cited by applicant]
US 20200146586A1 · Naveh et al. · 2020 [cited by applicant]
US 20200155835A1 · Wasserman et al. · 2020 [cited by applicant]
US 20200269041A1 · Zeevi et al. · 2020 [cited by applicant]
US 20200269042A1 · Giladi et al. · 2020 [cited by applicant]
US 20200269043A1 · Wasserman et al. · 2020 [cited by applicant]
US 20200306531A1 · Tran et al. · 2020 [cited by applicant]
US 20200368525A1 · Maag et al. · 2020 [cited by applicant]
US 20210031031A1 · Wasserman et al. · 2021 [cited by applicant]
US 20210038584A1 · Voloshin-Sela · 2021 [cited by applicant]
US 20210060334A1 · Avraham et al. · 2021 [cited by applicant]
US 20210069503A1 · Tran et al. · 2021 [cited by applicant]
US 20210187277A1 · Wasserman et al. · 2021 [cited by applicant]
US 20210196348A1 · Wasserman · 2021 [cited by applicant]
US 20210199640A1 · Patel et al. · 2021 [cited by applicant]
US 20210203250A1 · Wasserman · 2021 [cited by applicant]
US 20210268247A1 · Story et al. · 2021 [cited by applicant]
US 20210299440A1 · Deslauriers et al. · 2021 [cited by applicant]
US 20210330950A1 · Hagemann et al. · 2021 [cited by applicant]
US 20210379362A1 · Smith et al. · 2021 [cited by applicant]
US 20210408383A1 · Kalra et al. · 2021 [cited by applicant]
US 20220095997A1 · Wasserman · 2022 [cited by applicant]
US 20220096821A1 · Kirson et al. · 2022 [cited by applicant]
US 20220118249A1 · Bomzon et al. · 2022 [cited by applicant]
International Search Report and Written Opinion issued in application No. PCT/IB2019/059189 dated Dec. 19, 2019. [cited by applicant]